Skip to main content

Table 1 Main characteristics of the patients included

From: Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival

 Chemotherapy only N = 65Primary debulking Surgery N = 52Interval debulking surgery N = 91p-value
Age (years)68.4 (57–78)56.6 (47.8–67.25)58.8 (51–66.5)< 0.001
BMI25.0 (21.0–27.5)26.7 (22.1–29.7)24.6 (20.4–26.4)0.16
Histology
 Serous57 (87.7)30 (57.7)73 (80.2)< 0.001
 Mucinous1 (1.5)2 (3.8)1 (1.1) 
 Endometrioid04 (7.7)9 (9.9) 
 Transitional cell01 (1.9)0 
 Clear cell1 (1.5)4 (7.7)0 
 Mixed06 (11.5)5 (5.5) 
 Other3 (4.6)3 (5.8)2 (2.2) 
 Unknown3 (4.6)2 (3.8)1 (1.1) 
Metastasis site
 Intrahepatic22 (33.8)14 (26.9)20 (22.0)0.25
 Intra abdominal organ metastasesa11 (16.9)16 (30.8)15 (16.5)0.3
 Pleural effusion23 (35.4)9 (17.3)41 (45.1)0.003
 Pleural metastasis8 (12.3)3 (5.8)11 (12.1)0.42
 Over diaphragmatic metastases16 (24.6)12 (23.1)24 (26.4)0.9
 Unknown16 (24.6)00 
CA125 level at diagnosis4450 (378–2275)1451 (227–1553)2499 (530–3193)0.04
Initial chemotherapy
 Received platinum44 (67.7)47 (90.4)78 (85.7)0.002
 Received taxane40 (61.5)40 (76.9)73 (80.2)0.03
  1. Data are given as mean (interquartile range) or n (%)
  2. aIntra abdominal organs metastases: pancreas, spleen, digestive mucosa